Saturn V Capital Management

Saturn V Capital Management as of Dec. 31, 2022

Portfolio Holdings for Saturn V Capital Management

Saturn V Capital Management holds 19 positions in its portfolio as reported in the December 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Crinetics Pharmaceuticals In Common (CRNX) 9.4 $11M 624k 18.17
2seventy Bio Common (TSVT) 8.2 $9.9M 685k 14.43
Apellis Pharmaceuticals Common (APLS) 7.8 $9.4M 212k 44.34
Arcutis Biotherapeutics Common (ARQT) 7.3 $8.8M 487k 18.04
Cytokinetics Common (CYTK) 6.6 $8.0M 197k 40.48
Ascendis Pharma A/s Sponsored ADR (ASND) 6.6 $8.0M 68k 116.28
Morphic Hldg Common (MORF) 6.1 $7.4M 270k 27.33
Iteos Therapeutics Common (ITOS) 5.8 $7.0M 342k 20.55
Albireo Pharma Common 5.7 $6.9M 342k 20.08
Chinook Therapeutics Common 5.6 $6.7M 423k 15.90
Kalvista Pharmaceuticals Common (KALV) 5.6 $6.7M 720k 9.30
Cymabay Therapeutics Common 4.7 $5.7M 1.6M 3.55
Horizon Therapeutics SHS 4.7 $5.7M 69k 82.13
Sage Therapeutics Common (SAGE) 4.5 $5.4M 156k 34.39
Amicus Therapeutics Common (FOLD) 4.1 $4.9M 566k 8.64
Biocryst Pharmaceuticals Common (BCRX) 3.1 $3.8M 340k 11.03
Biogen Common (BIIB) 1.8 $2.2M 7.7k 283.29
Astria Therapeutics Common (ATXS) 1.3 $1.6M 170k 9.18
Theravance Biopharma Common (TBPH) 1.1 $1.3M 141k 9.44